No-carrier-added [18F]fluorobenzene derivatives as intermediates for built-up radiosyntheses

Current Radiopharmaceuticals

Volumn 3, Issue 2, 2010, Pages 127-160

  Ermert, Johannes ^a   Coenen, Heinz H ^a  

^a FORSCHUNGSZENTRUM JÜLICH   (Germany)

Author keywords

Built up synthesis; Fluorine 18; Nucleophilic substitution; Radiofluorination

Indexed keywords

2 OXOQUAZEPAM 2' F 18; 4 CHLORO 1 (4 FLUOROPHENYL)BUTAN 1 ONE F 18; 4 FLUOROBENZALDEHYDE F 18; 4 FLUOROMETARAMINOL F 18; 4 FLUOROPHENOL F 18; 4 FLUOROPHENYLALANINE F 18; 5 TERT BUTYL 2 (4 FLUOROPHENYL) 1,1,3,3 TETRAOXY 1,3 DITHIANE F 18; 6 (4 FLUOROBENZYLOXY) 9H PURIN 2 YLAMINE F 18; 6 FLUORODOPA F 18; 8 FLUORO 3 (4 FLUOROPHENYL) 3,4 DIHYDRO 1 ISOQUINOLINAMINE F 18; [2 (4 FLUOROBENZOYL)PHENYLAMINO] 3 [4 [2 (5 METHYL 2 PHENYLOXAZOL 4 YL)ETHOXY]PHENYL]PROPIONIC ACID F 18; ARECOLEIN F 18; BICALUTAMIDE F 18; FLUORINE 18; FLUOROBENZALDEHYDE F 18; FLUOROBENZENE; FLUOROBENZOIC ACID F 18; FLUORONITROBENZENE F 18; FLUORONOREPINEPHRINE F 18; FLUOROTOLBUTAMIDE F 18; KETONE DERIVATIVE; LIGAND; N [2 FLUORO 5 (3 IODOBENZOYL)BENZYL]BROMOACETAMIDE F 18; TRACER; UNCLASSIFIED DRUG;

ADDITION REACTION; ALKYLATION; ARTICLE; ARYLATION; BAEYER VILLIGER REACTION; CHIRALITY; DRUG SYNTHESIS; FLUORINATION; HALOGENATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORNER WADSWORTH EMMONS REACTION; ISOTOPE LABELING; KNOEVENAGEL CONDENSATION; POLYMERIZATION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOCHEMISTRY; RADIOFLUORINATION;

EID: 77954317757     PISSN: 18744710     EISSN: None     Source Type: Journal    
DOI: 10.2174/1874471011003020127     Document Type: Article

References (260)

1. Coenen, H.H. PET Chemistry: The Driving Force in Molecular Imaging. Ernst Schering Research Foundation Workshop 62. Schubiger, P.A.; Lehmann, L.; Friebe, M.; Eds.; Springer: Heidelberg, 2007, pp. 15-50.
2. Wüst, F. PET Chemistry: The Driving Force in Molecular Imaging. Ernst Schering Research Foundation Workshop 62. Schubiger, P.A.; Lehmann, L.; Friebe, M.; Eds. Springer: Heidelberg, 2007, pp. 51-78.
3. Wester, H.J.; Schotellius, M. PET Chemistry: The Driving Force in Molecular Imaging. Ernst Schering Research Foundation Work- shop 62. Schubiger, P.A.; Lehmann, L.; Friebe, M.; Eds. Springer: Heidelberg, 2007, pp. 79-111.
4. 18F]fluorophenyl- alanine. Appl. Radiat. Isot., 1987, 38, 1033-1038.
5. Plenevaux, A.; Fowler, J. S.; Dewey, S. L.; Wolf, A. P.; Guillaume, M. The synthesis of no-carrier-added DL-4-fluorine-18-labeled fluorodeprenyl via the nucleophilic aromatic substitution reaction. Appl. Radiat. Isot., 1991, 42, 121-127.
6. 18F-fluorinated aromatic-compounds through nucleophilic substitution and decarboxylation reactions. Appl. Radiat. Isot., 1992, 43, 1035-1040.
7. 18F-fluorination. Appl. Radiat. Isot., 1992, 43, 485- 944.
8. 18F]Fluorobenzaldehydes. Appl. Radiat. Isot., 1995, 46, 777-782.
9. 18F]fluorodexetimide. Syntheses and biodistribu- tion. Nucl. Med Biol., 1991, 18, 247-252.
10. 18F]fluoride ion? J. Label. Compd. Radiopharm., 1993, 33, 563-572.
11. 18F]fluoride. J. Fluor. Chem., 2007, 128, 1461-1468.
12. 18F-fluorinations of aromatic-molecules. Appl. Ra- diat. Isot., 1993, 44, 889-893.
13. 18F]GBR-13119. J. Label. Compd. Radiopharm., 1989, 27, 823-833.
14. 18F]fluorides via the nucleophilic aromatic substitution of electron-rich aromatic rings. J. Fluor. Chem., 1990, 48, 189-205.
15. 18F]fluoride in methoxy- substituted ortho-nitrobenzaldehydes-A systematic study J. Fluor. Chem., 2009, 130, 216-224.
16. 18F]fluorodexetimides, J. Label. Compd. Radiopharm., 1990, 28, 1189-1199.
17. 18F]fluorocate- chol. Appl. Radiat. Isot., 1991, 42, 673-681.
18. 18F]fluorides. Appl. Radiat. Isot., 1991, 42, 1209-1213.
19. 18F]fluoro-L-dopa. J. Nucl. Med., 1990, 31, 1247-1251.
20. 18F]fluoro-L-dopa with beta-tyrosinase. Appl. Radiat. Isot., 1999, 50, 1025-1032.
21. 18F]FDOPA. Radiochim. Acta, 2006, 94, 143-146.
22. 18F]Fluoro-L- DOPA and its remote routine production for PET investigations of dopaminergic systems. Appl. Radiat. Isot., 1993, 44, 645-649.
23. 18F]Fluoro-L-dopa via two chiral auxiliaries. Appl. Radiat. Isot., 1993, 44, 737-744.
24. 18F]fluoro-L-DOPA. Appl. Radiat. Isot., 2002, 57, 145-151.
25. 18F]fluoroveratraldehyde by nucleophilic halogen exchange at electron-rich precursors. J. Radioanal. Nucl. Chem., 2006, 270, 313-318.
26. 18F]fluorodop- amine for positron emission tomography studies of sympathetic nervous tissue. J. Med. Chem., 1991, 34, 861-863.
27. 18F]fluoro-L-dopa from no-carrier-added fluo- rine-18-fluoride. J. Nucl. Med., 1994, 35, 1996-2002.
28. 18F-fluorinated alpha-amino acids under phase-transfer conditions using (S)-NOBIN. Nucl. Med. Biol., 2004, 31, 597-603.
29. 18F-fluorinated aromatic amino acids. Appl. Radiat. Isot., 2006, 64, 355-359.
30. 18F]fluoronore- pinephrine via the nucleophilic aromatic substitution reaction. J. Med. Chem., 1991, 34, 767-71.
31. 18F-Fluorierung carbonylaktivierter aromatischer Aminosäu- rederivate. Berichte des Forschungszentrum Jülich, 2001, 3952, 1-121.
32. 18F]fluorometaraminol-PET tracers for the adrenergic ner- vous system of the heart. Bioorg. Med. Chem., 2001, 9, 677-694.
33. 18F]fluorophenylalanine. J. Fluor. Chem., 1996, 80, 117-124.
34. 18F]-1-bromo-4-fluorobenzene and its use in palladium- promoted cross-coupling reactions with organostannanes. Acta Chem. Scand., 1998, 52, 475-479.
35. 18F]Fluoroiodobenzene with Vinyl and Aryl Tin reagents. Acta Chem. Scand., 1998, 52, 480- 489.
36. 18F labeling of proteins. Nucl. Med. Biol., 1994, 21, 1005-1010.
37. 18F-labelled aromatic amino acids. Appl. Radiat. Isot., 2007, 65, 1227-1231.
38. 18F]Fluoroarylketones - useful bifunctional radiopharmaceutical intermediates. Appl. Radiat. Isot., 1994, 45, 599-608.
39. 18F]Fluoromethane. Appl. Radiat. Isot., 1994, 45, 69-74.
40. 18F]fluorophenol. Nucl. Med. Biol., 2002, 29, 255-262.
41. 18F]fluorophenol. J. Label. Compd. Radiopharm., 2001, 44 (Suppl 1), S1-3.
42. 18F]R91150 as a serotonin 5-HT2A receptor an- tagonist for PET. J. Label. Compd. Radiopharm., 2009, 52, 13-22.
43. 18F]fluorophenoxy)-benzylamines. J. Label. Compd. Radiopharm., 2004, 47, 443-455.
44. 18F]phenylketones. J. Label. Compd. Radiopharm., 2002, 45, 1045-1053.
45. 18F]fluorobenzaldehyde with decaborane. J. Label. Compd. Radiopharm., 2006, 49, 745-755.
46. 18F]Fluoro-benzyloxy)- 9H-purin-2-ylamine and 6-(3-[131I]Iodo-benzyloxy)-9H-purin-2- ylamine. Bioconjug. Chem., 2000, 11, 868-875.
47. 18F-labeled benzamides: high affinity sigma receptor ligands for PET imaging. Nucl. Med. Biol., 1997, 24, 333-340.
48. 18F]4- fluorobenzyl iodide in PET radiosynthesis: model alkylation stu- dies and its application in the design of dopamine D1 and D2 re- ceptor-based imaging agents. Nucl. Med. Biol., 1993, 20, 777-794.
49. Halldin, C.; Högberg, T.; Farde, L. Fluorine-18-labelled NCQ 115, a selective dopamine D2 receptor ligand. Preparation and positron emission tomography. Nucl. Med. Biol., 1994, 21, 627-631.
50. 18F]fluorobenzyl halides. Appl. Radiat. Isot., 2000, 52, 87-92.
51. 18F]fluorobenzyl bromides and their application to the preparation of labeled neuroleptics. J. Label. Compd. Radiopharm., 1991, 29, 373-380.
52. 18F]fluorotropapride, two speci- fic D2 receptor ligands for positron emission tomography: N.C.A. syntheses and animal studies. Appl. Radiat. Isot., 1992, 43, 1265- 1274.
53. 18F]NCQ- 115: a new selective reversible dopamine D2 receptor ligand. Nucl. Med. Biol., 1993, 20, 549-555.
54. 18F]fluorobenzene for PET. Bioconjug. Chem., 2009, 20, 817-823.
55. 18F](+)-4-fluorobenzyltrozamicol: in vitro binding studies and positron emission tomography studies in nonhuman primates. Synapse, 1997, 25, 368-380.
56. Elder, S. T.; Mach, R. H.; Nowak, P. A.; Moroney, D. A.; Rao, A. V.; Ehrenkaufer, R. L. E. Esters of 6-(4'-Fluorobenzylamino)-Carboline-3-Carboxylic Acid as Potential Benzodiazepine Imaging Agents for P.E.T. J. Label. Compd. Radiopharm., 1995, 36, 206-211.
57. 18F-labeled benzamides for studying the dopa- mine D2 receptor with positron emission tomography. J. Med. Chem., 1993, 36, 3707-3720.
58. Chumpradit, S.; Kung, M.P.; Billings, J.; Mach, R.; Kung, H.F. Fluorinated and iodinated dopamine agents: D2 imaging agents for PET and SPECT. J. Med. Chem., 1993, 36, 221-228.
59. 18F]FBT): molecular decomposition-reconstitution approach to vesamicol re- ceptor radioligands for positron emission tomography. Appl. Ra- diat. Isot., 1994, 45, 465-472.
60. 18F]MR18445, a 5-HT3 receptor partial ago- nist. Bioorg. Med. Chem., 1998, 6, 789-795.
61. 18F]spiro-FBT]: synthesis and biological evalua- tion of a high-affinity ligand for the vesicular acetylcholine trans- porter (VAChT). Nucl. Med. Biol., 1999, 26, 189-192.
62. Mach, R. H.; Nader, M. A.; Ehrenkaufer, R. L.; Gage, H. D.; Childers, S. R.; Hodges, L. M.; Hodges, M. M.; Davies, H. M. Fluorine-18-labeled tropane analogs for PET imaging studies of the do-pamine transporter. Synapse, 2000, 37, 109-117.
63. 18F]fluoroproxyfan): a potential radioligand for ima- ging histamine H3 receptors. J. Label. Compd. Radiopharm., 2000, 43, 873-882.
64. 18F]FDG, and [125I]IUDR. Nucl. Med. Biol., 2001, 28, 451-458.
65. 18F]FBFPA): a potential fluorine-18 labeled PET radiotracer for imaging sigma-1 receptors in the CNS. Synapse, 2005, 58, 267-274.
66. 18F]BNTI) as a potential PET imaging agent for DOP receptors. J. Label. Compd. Radiopharm., 2006, 49, 857-866.
67. Donohue, S.R.; Halldin, C.; Schou, M.; Hong, J.; Phebus, L.; Chernet, E.; Stephen, A.; Hitchcock, S.A.; Gardinier, K.M.; Ruley, K.M.; Krushinski, J.H.; Schaus, J.; Pike, V.W. Radiolabeling of a high potency cannabinoid subtype-1 receptor ligand, N-(4-fluoro- benzyl)-4-(3-(piperidin-1-yl)-indole-1-sulfonyl)benzamide (PipISB), with carbon-11 or fluorine-18. J. Label. Compd. Radiopharm., 2008, 51, 146-152.
68. 18F]fluorobenzyl)methylamino)methylphenylsulfanyl)benzonitrile, an F-18 fluorobenzyl analogue of DASB: synthesis, in vitro binding, and in vivo biodistribution studies. Bioconjug. Chem., 2007, 18, 1612-1618.
69. 18F-labeled biotin. Nucl. Med. Biol., 1993, 20, 401-405.
70. Damhaut, P.; Lemaire, C.; Plenevaux, A.; Brihaye, C.; Christiaens, L.; Comar, D. No-carrier-added asymmetric synthesis of alpha- methyl-alpha-amino acids labelled with fluorine-18. Tetrahedron, 1997, 53, 5785-5796.
71. 18F]Fluoro-L-dopa by chiral phase-transfer alkylation. Eur. J. Org. Chem., 2004, 2899-2904.
72. 18F]fluoride. Appl. Radiat. Isot., 2009, 67, 1650-1653.
73. 18F]fluoro-L-tyrosine by catalytic phase-transfer alkylation. J. Label. Compd. Radiopharm., 2001; 44 (Suppl 1), S857.
74. 18F]Fluorodopa via NCA nucleophilic fluorination. Appl. Radiat. Isot., 1991, 42, 629-635.
75. 18F]fluoro-L-DOPA. J. Label. Compd. Radiopharm., 2001, 44 (Suppl 1), S143-145.
76. Mishani, E.; McCarthy, T.J.; Brodbeck, R.; Dence, D.S.; Krause, J.E.; Welch, M.J. Synthesis and evaluation of a fluorine-18 labeled NK-1 antagonist. J. Label. Compd. Radiopharm., 1997, 40, 653-655.
77. 18F]fluorobenzyl)-4-[(5,6-dimethoxy-1-oxoindan-2-yl)me- thyl]piperidine for in vivo studies of acetylcholinesterase. Nucl. Med. Biol., 2000, 27, 741-744.
78. 18F- labeled 3-(1-benzyl-piperidin-4-yl)-1-(1-methyl-1H-indol-3-yl)pro- pan-1-ones for in vivo mapping of acetylcholinesterase. Nucl. Med. Biol., 2000, 27, 263-267.
79. 18F]fluorobenzyl)lpi- perazin-1-yl}methyl-1H-pyrrolo[2,3-b]pyridine: A potential dopa- mine D-4 receptor imaging agent. Radiochim. Acta, 2003, 91, 241- 245.
80. 18F]fluorobenzyl)-4-piperidinyl]ethyl]-6H- pyrrolo[3,2-f]-1,2-benzisoxazol-6-one for in vivo mapping of ace- tylcholinesterase. Nucl. Med. Commun., 2004, 25, 591-596.
81. 18F]fluoro-CP-118,954 for the in vivo mapping of acetylcholi- nesterase. Nucl. Med. Biol., 2005, 32, 185-191.
82. 18F]FMTP): Radiosynthesis and in vivo characterization in rats. Appl. Radiat. Isot., 2005, 63, 333-342.
83. 18F]fluorobenzyl)-2-methylpiperazin-1-yl]-2-oxoet- hoxy}phenyl)urea in an automated module. J. Label. Compd. Ra- diopharm., 2006, 49, 253-262.
84. 18F- labelled chromeno[3,4-c]pyridine-5-ones. Radiochim. Acta, 2006, 94, 119-122.
85. 18F-labeled 1- phenylpiperazine using mouse liver S9 fraction. Nucl. Med. Biol., 2006, 33, 165-172.
86. 18F-labeled G379. Nucl. Med. Biol., 2006, 33, 91-94.
87. 18F]GBR13119, a presy- naptic dopamine uptake antagonist. Appl. Radiat. Isot., 1988, 39, 279-282.
88. Kilbourn, M.R. Thiophenes as phenyl bio-isosteres: application in radiopharmaceutical design-I. Dopamine uptake antagonists. Nucl. Med. Biol., 1989, 16, 681-686.
89. 18F]NNC 12-0818; two potential radio- ligands for the dopamine transporter. Appl. Radiat. Isot., 1995, 46, 323-328.
90. 18F]flunarizine. Appl. Radiat. Isot., 1991, 42, 109-111.
91. 18F]-1,4-Benzodia- zepine-2-ones. J. Labelled Compd. Radiopharm., 1994, 34, 135- 145.
92. 18F]Fluorophenyl)-1,4-Benzo- diazepine-2-one. J. Label. Compd. Radiopharm., 1994, 34, 147- 156.
93. Shiue, C.Y.; Shiue, G.G.; Rysavy, J.A.; Pleus, R.C.; Huang, H.; Bai, L.Q.; Cornish, K.G.; Sunderland, J.J.; Frick, M.P. Fluorine-18 and carbon-11 labeled amphetamine analogs synthesis, distribution, binding characteristics in mice and rats and a PET study in mon- key. Nucl. Med. Biol., 1993, 20, 973-981.
94. 18F]fluoro-L-DOPA using 3,5,6,7,8,8a-hexahydro- 7,7,8a-trimethyl-[6s-(6α,8α,8α)]-6,8-methano-2H-1,4-benzoxazin- 2-one. J. Label. Compd. Radiopharm., 1995, 36, 409-423.
95. 18F]GBR 12936 via Wittig reaction for use in a dopamine reuptake site study. J. Label. Compd. Radio- pharm., 1993, 32, 253-254.
96. 18F-labelled resveratrol deriva- tive for small animal positron emission tomography. Amino Acids, 2005, 29, 415-428.
97. 18F]fluorobenzaldehyde using the Horner- Wadsworth-Emmons reaction. J. Label. Compd. Radiopharm., 2007, 50, 105-113.
98. 18F]fluorophenyl)-10,15,20-tris(3-methoxyphenyl)por- phyrin as a potential imaging agent for tumor. J. Label. Compd. Radiopharm., 2005, 48, 749-758.
99. 18F-labeled tracer suitable for routine clinical imaging of sst receptor-expressing tumors using po- sitron emission tomography. Clin. Cancer Res., 2004, 10, 3593- 3606.
100. Poethko, T.; Schottelius, M.; Thumshirn, G.; Herz, M.; Haubner, R.; Henriksen, G.; Kessler, H.; Schwaiger, M.; Wester, H.J. Chemoselective pre-conjugate radiohalogenation of unprotected mono- and multimeric peptides via oxime formation. Radiochim. Acta, 2004, 92, 317-327.
101. Poethko, T.; Schottelius, M.; Thumshirn, G.; Hersel, U.; Herz, M.; Henriksen, G.; Kessler, H.; Schwaiger, M.; Wester, H.J. Two-step methodology for high-yield routine radiohalogenation of peptides: 18 F-labeled RGD and octreotide analogs. J. Nucl. Med., 2004, 45, 892-902.
102. Flavell, R.R.; Kothari, P.; Bar-Dagan, M.; Synan, M.; Vallabhajosula, S.; Friedman, J.M.; Muir, T.W.; Ceccarini, G. Site-Specific 18 F-Labeling of the protein hormone leptin using a general two-step ligation procedure. J. Am. Chem. Soc., 2008, 130, 9106-9112.
103. 18F-labeled GnRH-I ana- logues with high GnRHR-targeting efficiency. Bioconjug. Chem., 2008, 19,1256-1268.
104. 18F]fluorinated aldehyde-containing prosthetic groups. Bioconjug. Chem., 2008, 19, 951-957.
105. Harki, D.A.; Satyamurthy, N.; Stout, D.B.; Phelps, M.E.; Dervan, P.B. In vivo imaging of pyrrole-imidazole polyamides with positron emission tomography. Proc. Natl. Acad. Sci. USA, 2008, 105, 13039-13044.
106. 18F]fluoropro- panethiol. Amino Acids, 2009, 37, 717-724.
107. 18F]fluoro- benzaldehyde by commercial synthesizer: amino-oxi peptide label- ling prosthetic group. Appl. Radiat. Isot., 2009, 67, 1664-1669.
108. 18F-labeled protein scaffold mo- lecules. J. Nucl. Med., 2008, 49, 804-813.
109. 18F-human se-rum albumin: a simple and efficient protein labeling method with 18 F using a hydrazone-formation method. Bioconjug. Chem., 2005, 16, 1329-1333.
110. 18F-fluorinated alde- hydes. Nucl. Med. Biol., 2006, 33, 173-183.
111. Rennen, H.J.; Laverman, P.; van Eerd, J.E.; Oyen, W.J.; Corstens, F.H.; Boerman, O.C. PET imaging of infection with a HYNIC- conjugated LTB4 antagonist labeled with F-18 via hydrazone for- mation. Nucl. Med. Biol., 2007, 34, 691-695.
112. 18F peptide labeling: hydrazone formation with HYNIC-conjugated c(RGDyK). Nucl. Med. Biol., 2006, 33, 677-683.
113. 18F-labeling agent. Bioconjug. Chem., 2003, 14, 1253-1259.
114. 18F]fluorobenzylidene)aminooxyhexyl]maleimide. Nucl. Med. Biol., 2007, 34, 5-15.
115. Li, X.; Link, J.M.; Stekhova, S.; Yagle, K.J.; Smith, C.; Krohn, K.A.; Tait, J.F. Site-specific labeling of annexin V with F-18 for apoptosis imaging. Bioconjug. Chem., 2008, 19, 1684-1688.
116. 18F]SFB). Amino Acids, 2009, 36, 283-295.
117. Zeng, W.; Yao, M.L.; Townsend, D.; Kabalka, G.; Wall, J.; Le Puil, M.; Biggerstaff, J.; Miao, W. Synthesis, biological evaluation and radiochemical labeling of a dansylhydrazone derivative as a potential imaging agent for apoptosis. Bioorg. Med. Chem. Lett., 2008, 18, 3573-3577.
118. 18F- Labeled benzylideneaniline derivatives as new ligands for - amyloid plaque imaging in Alzheimer's disease. Nucl. Med. Biol., 2009, 36, 107-116.
119. 18F]FFDI), a Potential PET Radiotracer for the Inducible Nitric Oxide Synthase, Curr. Radio- pharm., 2008, 1, 49-53.
120. Snyder, S.E.; Kume, A.; Jung, Y.W.; Connor, S.E.; Sherman, P.S.; Albin, R.L.; Wieland, D.M.; Kilbourn, M.R. Synthesis of carbon- 11-, fluorine-18-, and iodine-125-labeled GABAA-gated chloride ion channel blockers: substituted 5-tert-butyl-2-phenyl-1,3- dithianes and -dithiane oxides. J. Med. Chem., 1995, 38, 2663- 2671.
121. Kochanny, M.J.; VanBrocklin, H.F.; Kym, P.R.; Carlson, K.E.; O'Neil, J.P.; Bonasera, T.A.; Welch, M.J.; Katzenellenbogen, J.A. Fluorine-18-labeled progestin ketals: synthesis and target tissue up- take selectivity of potential imaging agents for receptor-positive breast tumors. J. Med. Chem., 1993, 36, 1120-1127.
122. Hwang, D.R.; Feliu, A.L.; Wolf, A.P.; MacGregor, R.R.; Fowler, J.S.; Amett, C.D.; Holland, H.J.; Carr, K.; Simon, E.J. Synthesis and evaluation of fluorinated derivatives of fentanyl as candidates for opiate receptor studies using positron emission tomography. J. Label. Compd. Radiopharm., 1986, 23, 277-293.
123. Zijlstra, S.; Gunawan, J.; Freytag, C.; Burchert, W. Synthesis and evaluation of fluorine-18 labelled compounds for imaging of bacte- rial infections with pet. Appl. Radiat. Isot., 2006, 64, 802-807.
124. 18F]MDL 100907 as serotonin 5-HT2A receptor antagonist for PET. J. Label. Compd. Radiopharm., 2009, 52, 6-12.
125. Daugherty, A.; Kilbourn, M.R.; Dence, C.S.; Sobel, B.E.; Thorpe, S.R. Quantitative assessment of lipoprotein metabolism by positron emission tomography with an fluorine-18-containing residualizing label. Nucl. Med. Biol., 1992, 19, 411-416.
126. Kilbourn, M.R.; Dence, C.S.; Welch, M.J.; Mathias, C.J. Fluorine- 18 labeling of proteins. J. Nucl. Med., 1987, 28, 462-470.
127. de Vries, E.F.; Vroegh, J.; Elsinga, P.H.; Vaalburg, W. Evaluation of fluorine-18-labeled alkylating agents as potential synthons for the labeling of oligonucleotides. Appl. Radiat. Isot., 2003, 58, 469- 476.
128. 18F]fluorophenacyl bromide: The use of polymer supported per- bromide. Appl. Radiat. Isot., 1993, 44, 981-983.
129. 18F]fluoride. Appl. Radiat. Isot., 1991, 42, 1043-1047.
130. Ding, Y.S.; Fowler, J.S.; Dewey, S.L.; Wolf, A.P.; Logan, J.; Gatley, S.J.; Volkow, N.D.; Shea, C.; Taylor, D.P. Synthesis and PET studies of fluorine-18-BMY 14802: a potential antipsychotic drug. J. Nucl. Med., 1993, 34, 246-254.
131. Shiue, C.Y.; Fowler, J.S.; Wolf, A.P.; Watanabe, M.; Arnett, C.D. Syntheses and specific activity determinations of no-carrier-added F-18-labeled neuroleptic drugs. J. Nucl. Med.,1985, 26, 181-186.
132. 18F-labelled haloperidol. J. Label. Compd. Radio- pharm., 1985, 22, 721-733.
133. Shiue, C.Y.; Fowler, J.S.; Wolf, A.P.; McPherson, D.W.; Arnett, C.D.; Zecca, L. No-carrier-added fluorine-18-labeled N- methylspiroperidol: synthesis and biodistribution in mice. J. Nucl. Med., 1986, 27, 226-234.
134. 18F. J. Label. Compd. Radiopharm., 1990, 28, 73-81.
135. Moerlein, S. M.; Banks, W. R.; Parkinson, D. Production of fluo- rine-18-labeled (3-N-methyl)benperidol for PET investigation of cerebral dopaminergic receptor binding. Appl. Radiat. Isot., 1992, 43, 913-917.
136. 18F-labeled butyrophenone neuroleptic agents. Appl. Radiat. Isot., 1994, 45, 75-81.
137. 18F]PNBS) in rats. Nucl. Med. Biol., 1993, 20, 269-278.
138. Vaidyanathan, G.; Bigner, D.D.; Zalutsky, M.R. Fluorine-18- labeled monoclonal antibody fragments: a potential approach for combining radioimmunoscintigraphy and positron emission tomo- graphy. J. Nucl. Med., 1992, 33, 1535-1541.
139. Vaidyanathan, G.; Zalutsky, M. R. Fluorine-18-labeled [Nle4,D- Phe7]-MSH, an -melanocyte stimulating hormone analog. Nucl. Med. Biol., 1997, 24, 171-178.
140. 18F]fluoro-benzoate. Acta Chem. Scand., 1998, 52, 1034-1039.
141. 18F]SFB) for labeling bombesin derivatives. Wissen- schaftlich-Technische Berichte - Forschungszentrum Rossendorf, 1999, 283, 61-62.
142. Vaidyanathan, G.; Zalutsky, M.R. Fluorine-18 labeled chemotactic peptides: a potential approach for the PET imaging of bacterial in- fection. Nucl. Med. Biol., 1995, 22, 759-764.
143. Bergmann, R.; Helling, R.; Heichert, C.; Scheunemann, M.; Mäding, P.; Wittrisch, H.; Johannsen, B.; Henle, T. Radio fluorination and positron emission tomography (PET) as a new approach to study the in vivo distribution and elimination of the advanced glycation endproducts N.epsilon.-carboxymethyllysine (CML) and N.epsilon.-carboxyethyllysine (CEL). Food, 2001, 45, 182.
144. 18F-Endothelin-1, a positron emis- sion tomography (PET) radioligand for the endothelin receptor sys- tem: radiosynthesis and in vivo imaging using microPET. Clin. Sci. 2002, 103 (Suppl.48), 4S-8S.
145. 18F-labeled neurotensin(8-13) analogs. Nucl. Med. Biol., 2002, 29, 61-72.
146. 18F-labeled PEGylated RGD peptide Eur. J. Nucl. Med. Mol. Imag., 2004, 31, 1081-1089.
147. 18F-labeled linear peptides. Eur. J. Nucl. Med. Mol. Imaging, 2002, 29, 754-759.
148. 18F]fluorobenzoate. Appl. Radiat. Isot., 2003, 59, 43-48.
149. 18F-labeled RGD peptide: initial evaluation for imaging brain tumor angiogenesis. Nucl. Med. Biol., 2004, 31, 179-189.
150. 18F- and 64Cu-labeled RGD pep- tide. Bioconjug. Chem., 2004, 15, 41-49.
151. 18F- annexin V as a PET imaging agent in an animal model of apopto- sis. J. Nucl. Med., 2005, 46, 658-666.
152. 18F-labeled dimeric RGD peptide. Mol. Imaging 2004, 3, 96-104.
153. 18F- and 19F-labeled insulin: a new radiotracer for PET-based molecular imaging studies. J. Med. Chem., 2006, 49, 1466-1474.
154. 18F-FRGD2. J. Nucl. Med., 2006, 47, 113-121.
155. Cheng, D.; Yin, D.; Zhang, L.; Wang, M.; Li, G.; Wang, Y. Prepa- ration of the novel fluorine-18-labeled VIP analog for PET imaging studies using two different synthesis methods. J. Fluor. Chem., 2007, 128, 196-201.
156. 18F-(R8,15,21, L17)-vasoactive intestinal peptide and preliminary evaluation in mice bearing C26 colorectal tumours. Nucl. Med. Commun., 2007, 28, 501-506.
157. 18F]fluoroannexin for imaging apoptosis with PET. Bioconjug. Chem., 2004, 15, 373-379.
158. Pietzsch, J.; Bergmann, R.; Rode, K.; Hultsch, C.; Pawelke, B.; Wuest, F.; van den Hoff, J. Fluorine-18 radiolabeling of low- density lipoproteins: a potential approach for characterization and differentiation of metabolism of native and oxidized low-density lipoproteins in vivo. Nucl. Med. Biol. 2004, 31, 1043-1050.
159. 18F]FB-[R(8,15,21), L17]-VIP as a PET imaging agent for tumor overexpressed VIP receptors. Chem. Biol. Drug Des., 2006, 68, 319-325.
160. 18F- labelled isopeptide N(ε)-(γ-glutamyl)-L-lysine. Amino Acids 2005, 29, 405-413.
161. 18F-labeled N- -fructoselysine as a model of Amadori products. Nucl. Med. Biol., 2006, 33, 865-873.
162. 18F-labeled T84.66 anti- carcinoembryonic antigen diabody. J. Nucl. Med., 2007, 48, 304- 310.
163. 18F]fluorobenzoyl A20FMDV2 for in vivo imaging of in- tegrin alphavbeta6 expression with positron emission tomography. Cancer Res., 2007, 67, 7833-7840.
164. 18F-FPRGD2): synthesis and microPET imaging of v alphavbeta integrin expression. Eur. J. Nucl. Med. Mol. Imaging, 2007, 34, 1823-1831.
165. Hultsch, C.; Berndt, M.; Bergmann, R.; Wuest, F. Radiolabeling of multimeric neurotensin(8-13) analogs with the short-lived positron emitter fluorine-18. Appl. Radiat. Isot. 2007, 65, 818-826.
166. 18F-labeled AS1411. J. Label. Compd. Radiopharm., 2007, 50, 1255-1259.
167. 18F-Labeled BBN- RGD Heterodimer for Prostate Cancer Imaging. J. Nucl. Med., 2008, 49, 453-4561.
168. 18F]fluoropropionyl-peptides. J. Med. Chem., 2008, 51, 5901-5904.
169. 18F-FB-PEG3- Glu-RGD-BBN. J. Med. Chem., 2009, 52, 425-432.
170. 18F]fluorobenzoate. Nucl. Med. Biol., 1992, 19, 275-281.
171. Lee, S. Y.; Choe, Y. S.; Kim, D. H.; Park, B. N.; Kim, S. E.; Choi, Y.; Lee, K. H.; Lee, J.; Kim, B.T. A simple and efficient in vitro method for metabolism studies of radiotracers. Nucl. Med. Biol., 2001, 28, 391-395
172. Yang, Z. Y.; Perry, B.; Mukherjee, J. Fluorinated benzazepines: 1. synthesis, radiosynthesis and biological evaluation of a series of substituted benzazepines as potential radiotracers for positron emission tomographic studies of dopamine D-1 receptors. Nucl. Med. Biol., 1996, 23, 793-805.
173. 18F ion. A new route to aryl fluorides of high specific activity. J. Chem. Soc. Chem. Commun., 1983, 108-109.
174. Attina, M.; Cacace, F.; Wolf, A. P. Labeled aryl fluorides from the nucleophilic displacement of activated nitro groups by fluoride-18 ion J. Label. Compd. Radiopharm., 1983, 20, 501-514.
175. 18F]fluorocarboxylic acids. Appl. Radiat. Isot., 1994, 45, 715-727.
176. 18F]fluorobenzoate. J. Label. Compd. Radiopharm., 2001, 44, 509- 519.
177. 18F]fluorophenyl)benzimidazole. J. Label. Compd. Radiopharm., 2004, 47, 139-145.
178. 18F]fluorobenzoate and its application to the label- ing of a monoclonal antibody fragment. Bioconjug. Chem., 1994, 5, 352-356.
179. 18F. Nat. Protoc., 2006, 1, 1655-1661.
180. 18F-conjugate of omega-conotoxin GVIA for the potential imaging of N-type Ca2+ channels in the brain by positron emission tomography J. Label. Compd. Radiopharm., 2006, 49, 269-283.
181. 18F]fluorobenzoyl octreotide and biodistribution in tumour-bearing Lewis rats. J. Label. Compd. Radiopharm. 1999, 42 (Suppl 1), S720-722.
182. Wester, H. J.; Hamacher, K.; Stöcklin, G. A comparative study of n.c.a. fluorine-18 labeling of proteins via acylation and photo- chemical conjugation. Nucl. Med. Biol., 1996, 23, 365-372.
183. 18F]SFB). Appl. Radiat. Isot., 2005, 63, 329-332.
184. 18F-labelled recombinant annexin-V derivative, for identification and quantification of apoptotic cells with PET. Appl. Radiat. Isot., 2003, 58, 201-207.
185. 18F-labelled annexin V: a PET tracer for apoptosis imaging. Eur. J. Nucl. Med. Mol. Imaging 2004, 31, 469-474.
186. 18F]fluorobenzoate using a Siemens/CTI chemistry process control unit (CPCU). Appl. Radiat. Isot., 2007, 65, 199-203.
187. 18F-label the vasoactive transmitter urotensin-II as a ligand for positron emission tomography. Nucl. Med. Biol., 2008, 35, 725-731.
188. 18F]fluorobenzene and pyridinecarbohydrazide-folates as po- tential PET radiopharmaceuticals. J. Label. Compd. Radiopharm., 2006, 49, 125-137.
189. Lang, L.; Jagoda, E.; Schmall, B.; Vuong, B. K.; Adams, H. R.; Nelson, D. L.; Carson, R. E.; Eckelman, W. C. Development of fluorine-18-labeled 5-HT1A antagonists. J. Med. Chem., 1999, 42, 1576-1586.
190. Kiesewetter, D. O.; Jagoda, E. M.; Kao, C. H. K.; Ma, Y.; Ravasi, L.; Shimoji, K.; Szajek, L. P.; Eckelman, W. C. Fluoro-, bromo-, and iodopaclitaxel derivatives: synthesis and biological evaluation. Nucl. Med. Biol., 2003, 30, 11-24.
191. 18F]labelled peptides for positron emission to- mography. Bioorg. Med. Chem. Lett., 2000, 10, 1501-1503.
192. 18F]fluorobenzamido)ethyl]maleimide, and synthe- sis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression. J. Nucl. Med., 2006, 47, 1172-1180.
193. Kiesewetter, D. O.; Kraemer-Marek, G.; Ma, Y.; Capala, J. Radio- labeling of HER2-specific Affibody molecule with F-18. J. Fluor. Chem. 2008, 129, 799-806.
194. 18F]FBEM-Z(HER2:342)-Affibody mole- cule-a new molecular tracer for in vivo monitoring of HER2 ex- pression by positron emission tomography. Eur. J. Nucl. Med. Mol. Imaging, 2008, 35, 1008-1018.
195. 18F-labeled neurotensin(8-13) via copper-mediated 1,3-dipolar [3+2]Cy- cloaddition reaction. Lett. Drug Design Discov., 2007, 4, 279-285.
196. 18F]fluorobenzoate: a putatively more stable prosthetic group for the fluorine-18 labeling of biomolecules via click chemistry. Curr. Radiopharm., 2009, 2, 63-74.
197. 18F-labelled FK960, a candidate anti-dementia drug, and PET studies in conscious monkeys. J. Label. Compd. Radio- pharm., 2002, 45, 1219-1228.
198. 18F-fluorobenzoate idarubicin derivative as new poten- tial PET radiotracer to predict chemotherapy resistance. J. Label. Compd. Radiopharm., 2005, 48, 819-827.
199. 18F-labeled delta- opioid receptor antagonist derived from the Dmt-Tic pharma- cophore for positron emission tomography imaging. J. Med. Chem., 2008, 51, 1817-1823.
200. 18F]-DAFBA): A novel potential PET probe to image melanoma tumors. Biocon- jug. Chem. 2009, 20, 583-590.
201. Chen, Y.; Foss, C. A.; Byun, Y.; Nimmagadda, S.; Pullambhatla, M.; Fox, J. J.; Castanares, M.; Lupold, S. E.; Babich, J. W.;Mease,. C.; Pomper, M. G. Radiohalogenated prostate-specific mem- brane antigen (PSMA)-based ureas as imaging agents for prostate cancer. J. Med. Chem., 2008, 51, 7933-7943.
202. 18F]fluoroanilino- quinazolines. J. Label. Compd. Radiopharm., 2001, 44 (Suppl 1), S880-882.
203. Constantinou, M.; Shah, F.; Pike, V.W. Radiofluoridations of m- substituted nitrobenzene. J. Label. Compd. Radiopharm., 2001, 44 (Suppl 1), S889-891.
204. 18F]Flumazenil via instant fluorination, a new nucleophilic fluorination method. J. Label. Compd. Radio- pharm., 2001, 44 1), S930-932.
205. Lazarova, N.; Siméon, F. G.; Musachio, J. L.; Lu, S. Y.; Pike, V. W. Integration of a microwave reactor with Synthia to provide a fully automated radiofluorination module. J. Label. Compd. Radio- pharm., 2007, 50, 463-465.
206. 18F]F-K-222 - A comparative study. J. Label. Compd. Radiopharm., 2002, 45, 1103-1113.
207. 18F-labeled aryl fluorides. J. Label. Compd. Radiopharm., 1984, 21, 533-547.
208. 18F-labeled guanidines. J. Med. Chem., 1991, 34, 1867-1870.
209. 18F]WIN 44577. J. Label. Compd. Radiopharm., 1988, 25, 1245-1254.
210. 18F]fluoroanilino)quinazoline: a prospective irreversible EGFR binding probe. J. Label. Compd. Radiopharm., 2005, 48, 109-115.
211. 18F- selective ligand of serotonergic receptor (5HT2 antagonist). J. Chem. Soc. Perkin Trans., 1992, 3185-3188.
212. 18F]fluoroaniline. J. Label. Compd. Radiopharm., 2006, 49, 1037-1050.
213. 18F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase. Nucl. Med. Biol., 2001, 28, 359-374.
214. 18F-radiolabeled hydroxyflutamide derivatives. Bioorg. Med. Chem., 2005, 13, 6195-6205.
215. 18FTFMPP). Nucl. Med. Biol., 1997, 24, 269-273.
216. Dissoki, S.; Laky, D.; Mishani, E. Fluorine-18 labeling of ML04, presently the most promising irreversible inhibitor candidate for visualization of EGFR in cancer. J. Label. Compd. Radiopharm., 2006, 49, 533-543.
217. 18F]AM5144 and related pyrazole compounds. Nucl. Med. Biol., 2005, 32, 361-366.
218. 18F- labeled S-aryl-cysteine and a radiolabeled peptide. J. Label. Compd. Radiopharm., 2002, 45, 1229-1238.
219. 18F-Iressa and related molecular probes. J. Label. Compd. Radiopharm., 2005, 48, 829-43.
220. Franke, K.; Patt, J. T.; Patt, M.; Kupsch, H.; Steinbach, J. A new technique for radiolabelling of humic substances. Radiochim. Acta, 2004, 92, 359-362.
221. Hultsch, C.; Blank, O.; Wester, H.J.; Heinrich, M.R. Radical fluoroarylation in radiochemical synthesis. Tetrahedron Lett., 2008, 49, 1881-1883.
222. 18F-fluoroarylation of unsaturated -, - and -amino ac- ids, application to a radiolabelled analogue of baclofen. Tetrahe- dron, 2008, 64, 11846-11851.
223. Ilovich, O.; Jacobson, O.; Aviv, Y.; Litchi, A.; Chisin, R.; Mishani, E. Formation of fluorine-18 labeled diaryl ureas-labeled VEGFR- 2/PDGFR dual inhibitors as molecular imaging agents for angio- genesis. Bioorg. Med. Chem., 2008, 16, 4242-4251.
224. 18F]RP-62203: A high affinity and selective radioligand as a potential PET tracerfor serotonine 5-HT2A receptor. J. Label. Compd. Radiopharm., 1994, 35, 497-499.
225. 18F]RP-62203, a selective ligand for the study of sero- tonin receptors (5-HT2) by rapid in-situ piperazine formation. Appl. Radiat. Isot., 1994, 45, 1085-1091.
226. 18F labeled aryl azides for positron labeling of biochemical molecules. J. Org. Chem., 1995; 60, 6680- 6681.
227. Berridge, M. S.; Crouzel, C.; Comar, D. Aromatic fluorination with n.c.a. F-18 fluoride: A comparative study J. Label. Compd. Radio- pharm., 1985, 22, 687-694.
228. 18F]fluorobenzylguanidine. Nucl. Med. Biol., 1994, 21, 97-103.
229. 18F]fluoride substitution of meta-halo (F, Cl, Br, I)-benzonitrile derivatives. Appl. Radiat. Isot. 2008, 66, 1396-1402.
230. 18F]Fluoro-3- iodobenzyl)guanidine, a potential MIBG analogue for positron emission tomography. J. Med. Chem., 1994, 37, 3655-3662.
231. 18F for in vivo PET imaging. J. Label. Compd. Radiopharm., 1997, 39, 319- 330.
232. Tavitian, B.; Terrazzino, S.; Kuhnast, B.; Marzabal, S.; Stettler, O.; Dollé, F.; Deverre, J. R.; Jobert, A.; Hinnen, F.; Bendriem, B.; Crouzel, C.; Di Giamberardino, L. In vivo imaging of oligonucleo- tides with positron emission tomography. Nat. Med., 1998, 4, 467- 471.
233. Kuhnast, B.; Dollé, F.; Terrazzino, S.; Rousseau, B. Loc'h, C.; Vaufrey, F.; Hinnen, F.; Doignon, I.; Pillon, F.; David, C.; Crouzel, C.; Tavitian, B. General method to label antisense oligonucleotides with radioactive halogens for pharmacological and imaging studies. Bioconjug. Chem., 2000, 11, 627-636.
234. Kuhnast, B.; Dollé, F.; Tavitian, B. Fluorine-18 labeling of peptide nucleic acids. J. Label. Compd. Radiopharm., 2002, 45, 1-11.
235. 18F]fluorobenzyl)-2-bromoacetamide reagent. J. Label. Compd. Radiopharm., 2003, 46, 1093-1103.
236. Kuhnast, B.; Klussmann, S.; Hinnen, F.; Boisgard, R.; Rousseau, B.; Fürste, J.P.; Tavitian, B.; Dollé, F. Fluorine-18-and iodine-125- labelling of spiegelmers. J. Label. Compd. Radiopharm., 2003, 46, 1205-1219.
237. Kuhnast, B.; Hinnen, F.; Hamzavi, R.; Boisgard, R.; Tavitian, B.; Nielsen, P.E.; Dollé, F. Fluorine-18 labelling of PNAs functional- ized at their pseudo-peptidic backbone for imaging studies with PET. J. Label. Compd. Radiopharm., 2005, 48, 51-61.
238. Kuhnast, B.; Dollé, F.; Vaufrey, F.; Tavitian, B.; Crouzel, C. Fluo- rine-18 labeling of oligonucleotides bearing chemically-modified ribose-phosphate backbones. J. Label. Compd. Radiopharm., 2000, 43, 837-848.
239. 18F-labelled Spiegelmers: a new class of oligonucleo- tidic radiopharmaceuticals. Eur. J. Nucl. Med. Mol. Imaging, 2005, 32, 470-477.
240. 18F]fluorobenzyl)-2-bromoacetamide: an 18 F-labeled reagent for the prosthetic radiolabeling of oligonucleo- tides. J. Label. Compd. Radiopharm., 2008, 51, 352-356.
241. Garg, P. K.; Garg, S.; Zalutsky, M. R. Fluorine-18 labeling of monoclonal antibodies andfragments with preservation of im- munoreactivity. Bioconjug. Chem., 1991, 2, 44-49.
242. 18F-labeled Mel-14 F(ab')2 fragment in normal dogs. Nucl. Med. Biol., 1994, 21, 911-919.
243. 18F]fluorobenzylamine. Appl. Radiat. Isot., 1998, 49, 1551-1556.
244. 18F for PET imaging of folate receptor-positive tu- mors. J. Nucl. Med., 2006, 47, 1153-1160.
245. Li, Z.; Ding, Y. S.; Gifford, A.; Fowler, J. S.; Gatley, J. S. Synthe- sis of structurally identical fluorine-18 and iodine isotope labeling compounds for comparative imaging. Bioconjug. Chem., 2003, 14, 287-294.
246. Shiue, G. G.; Schirrmacher, R.; Shiue, C. Y.; Alave, A. A. Synthe- sis of fluorine-18 labeled sulfonureas as -cell imaging agents. J. Label. Compd. Radiopharm., 2001, 44, 127-139.
247. 18F]bicalutamide, 4-[76Br]bromobicalutamide, and 4-[76Br]bromo- thiobicalutamide as non-steroidal androgens for prostate cancer im- aging. J. Med. Chem., 2007, 50, 1028-1040.
248. 18F]fluorobenzene. J. Label. Compd. Radiopharm., 2004, 47, 429-441.
249. 18F- labeled synthon 4-fluorobromobenzene and 4-fluoroiodobenzene. Appl. Radiat. Isot., 1994, 45, 105-111.
250. 18F]fluoroalkylarenes? J. Label. Compd. Radiopharm., 1995, 37, 581-583.
251. 18F]fluoroiodobenzene and its applications in Sonogashira cross-coupling reactions. J. Label. Compd. Radiopharm., 2003, 46, 699-713.
252. 18F]Fluoride. J. Am. Chem. Soc., 2007, 129, 8018-2025.
253. Marrière, E.; Rouden, J.; Tadino, V.; Lasne, M. C. Synthesis of analogues of (-)-cytisine for in vivo studies of nicotinic receptors using positron emission tomography. Org. Lett., 2000, 2, 1121- 1124.
254. 18F]fluoroiodobenzene. J. Label. Compd. Radiopharm., 2004, 47, 457-468.
255. 18F]fluoroiodobenzene as radiotracer for positron emission tomo- graphy (PET). Org. Biomol. Chem., 2005, 3, 503-507.
256. 18F]fluoroiodobenzene. J. Label. Compd. Radiopharm., 2006, 49, 817-827.
257. 18F]RP 62203, a potent and selective serotonin 5-HT2A receptor antagonist and biological evaluation with ex-vivo autoradiography. J. Label. Compd. Radio- pharm., 1999, 42, S69-71.
258. 18F-labelled 2 receptor ligands for positron emission tomography (PET). J. Label. Compd. Radiopharm., 2005, 48, 31-43.
259. 18F- fluoroarylation reactions. J. Organomet. Chem., 2007, 692, 4084- 4092.
260. Lee, B. C.; Dence, C. S.; Zhou, H. B.; Parent, E. E.; Welch, M. J.; Katzenellenbogen, J. A. Fluorine-18 labeling and biodistribution studies on peroxisome proliferator-activated receptor-gamma ligands: potential positron emission tomography imaging agents, Nucl. Med. Biol., 2009, 36, 147-153.